A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

Key Inclusion Criteria: * Healthy male and non-pregnant female patients ≥18 years and \<65 years * Clinical diagnosis of tinea pedis * Positive baseline KOH * Clinical signs and symptoms score of the target lesion is at least 6, including a minimum score of at least 2 for erythema AND a minimum score of 2 for either scaling or pruritus (on a scale of 0-3, where 2 indicates moderate severity) * Patients must be able to swallow capsules intact * Use acceptable birth control methods Key Exclusion Criteria: * Major organ system disease or clinical infection * Poorly controlled diabetes mellitus * Pregnant or lactating * Confluent, diffuse moccasin-type tinea pedis * Presence of onychomycosis involving a) more than 5 toe nails, b) any fingernail * Recent use of topical corticosteroids, topical antibiotics, or topical antifungal therapy to the foot * Recent use of systemic corticosteroids or antifungal therapy * Known(HIV)infection * Known significant hepatic, or hematologic impairment .Requirement for treatment with concomitant antimicrobial or systemic antifungal therapy for any reason.